Articles de revues sur le sujet « Ms polymorphism »
Créez une référence correcte selon les styles APA, MLA, Chicago, Harvard et plusieurs autres
Consultez les 50 meilleurs articles de revues pour votre recherche sur le sujet « Ms polymorphism ».
À côté de chaque source dans la liste de références il y a un bouton « Ajouter à la bibliographie ». Cliquez sur ce bouton, et nous générerons automatiquement la référence bibliographique pour la source choisie selon votre style de citation préféré : APA, MLA, Harvard, Vancouver, Chicago, etc.
Vous pouvez aussi télécharger le texte intégral de la publication scolaire au format pdf et consulter son résumé en ligne lorsque ces informations sont inclues dans les métadonnées.
Parcourez les articles de revues sur diverses disciplines et organisez correctement votre bibliographie.
Cakina, Suat, Ozgul Ocak, Adile Ozkan, Selma Yucel, and Handan Isin Ozisik Karaman. "Vitamin D receptor gene polymorphisms in multiple sclerosis disease: A case-control study." Revista Romana de Medicina de Laborator 26, no. 4 (2018): 489–95. http://dx.doi.org/10.2478/rrlm-2018-0028.
Texte intégralBulan, B., AY Hoscan, SN Keskin, et al. "Vitamin D receptor polymorphisms among the Turkish population are associated with multiple sclerosis." Balkan Journal of Medical Genetics 25, no. 1 (2022): 41–50. http://dx.doi.org/10.2478/bjmg-2022-0003.
Texte intégralSteinman, L., J. R. Oksenberg, and C. C. A. Bernard. "Polymorphism in MS." Neurology 42, no. 2 (1992): 466. http://dx.doi.org/10.1212/wnl.42.2.466-b.
Texte intégralHillert, J., and O. Olerup. "Polymorphism in MS." Neurology 42, no. 2 (1992): 467. http://dx.doi.org/10.1212/wnl.42.2.467.
Texte intégralTitova, M. A., V. M. Alifirova, N. F. Musina та T. N. Nikolaeva. "The Role of <i>TNF</i>-α, <i>TNFRSF1A</i>, and <i>CD40</i> Genes Polymorfisms in Multiple Sclerosis in Tomsk Region". Нейрохимия 40, № 3 (2023): 292–98. http://dx.doi.org/10.31857/s1027813323020152.
Texte intégralGade-Andavolu, Radhika, David E. Comings, James MacMurray, et al. "RANTES: a genetic risk marker for multiple sclerosis." Multiple Sclerosis Journal 10, no. 5 (2004): 536–39. http://dx.doi.org/10.1191/1352458504ms1080oa.
Texte intégralDolcetti, Ettore, Antonio Bruno, Federica Azzolini, et al. "The BDNF Val66Met Polymorphism (rs6265) Modulates Inflammation and Neurodegeneration in the Early Phases of Multiple Sclerosis." Genes 13, no. 2 (2022): 332. http://dx.doi.org/10.3390/genes13020332.
Texte intégralAraújo, Eduarda Pontes dos Santos, Severina Carla Vieira da Cunha Lima, Ony Araújo Galdino, Ricardo Fernando Arrais, Karla Simone Costa de Souza, and Adriana Augusto de Rezende. "Association of CYP2R1 and VDR Polymorphisms with Metabolic Syndrome Components in Non-Diabetic Brazilian Adolescents." Nutrients 14, no. 21 (2022): 4612. http://dx.doi.org/10.3390/nu14214612.
Texte intégralĎurmanová, Vladimíra, I. Shawkatová, J. Javor, et al. "VLA4 Gene Polymorphism and Susceptibility to Multiple Sclerosis in Slovaks." Folia Biologica 61, no. 1 (2015): 8–13. http://dx.doi.org/10.14712/fb2015061010008.
Texte intégralMartinez-Hernandez, A., E. E. Perez-Guerrero, M. A. Macias-Islas, et al. "Polymorphisms CYP2R1 rs10766197 and CYP27B1 rs10877012 in Multiple Sclerosis: A Case-Control Study." Journal of Immunology Research 2021 (December 23, 2021): 1–11. http://dx.doi.org/10.1155/2021/7523997.
Texte intégralIto, Soichiro, Takeshi Hirota, Miyu Yanai, et al. "Effects of Genetic Polymorphisms of Cathepsin A on Metabolism of Tenofovir Alafenamide." Genes 12, no. 12 (2021): 2026. http://dx.doi.org/10.3390/genes12122026.
Texte intégralKhaliel, Alaa H., Ahmed A. Abbas, Anmar O. Hatem, and Ahmed S. Abdulamir. "THE IMPACT OF VERY LATE ANTIGEN 4 POLYMORPHISM ON DRUG RESPONSIVENESS IN PATIENTS WITH MULTIPLE SCLEROSIS INITIATION." Iraqi Journal of Medical Sciences 20, no. 1 (2022): 83–89. http://dx.doi.org/10.22578/ijms.20.1.11.
Texte intégralSuriyaprom, Kanjana, Rungsunn Tungtrongchitr, and Pisit Namjuntra. "Associations of Resistin Levels with Resistin Gene Polymorphism and Metabolic Syndrome in Thais / Asocijacija Nivoa Rezistina Sa Polimorfizmom Gena Za Rezistin I Metaboličkim Sindromom Kod Tajlanđana." Journal of Medical Biochemistry 34, no. 2 (2015): 170–78. http://dx.doi.org/10.2478/jomb-2014-0034.
Texte intégralBarto, Libor, and Ondřej Draganov. "The minimal arity of near unanimity polymorphisms." Mathematica Slovaca 69, no. 2 (2019): 297–310. http://dx.doi.org/10.1515/ms-2017-0223.
Texte intégralЮ.И., Шрамко,, Агеева, Е.С., Малый, К.Д., et al. "Association of Adiponectin and Leptin Genetic Polymorphisms with Clinical Manifestations of Metabolic Syndrome." Nauchno-prakticheskii zhurnal «Medicinskaia genetika, no. 9 (September 30, 2022): 8–12. http://dx.doi.org/10.25557/2073-7998.2022.09.8-12.
Texte intégralGreve, Bernhard, Rostislav Simonenko, Zsolt Illes, et al. "Multiple sclerosis and the CTLA4 autoimmunity polymorphism CT60: no association in patients from Germany, Hungary and Poland." Multiple Sclerosis Journal 14, no. 2 (2007): 153–58. http://dx.doi.org/10.1177/1352458507082357.
Texte intégralIbrahim, Sherine M., and Afaf A. Bastawy. "The Relevance of Single-nucleotide Polymorphism +62 G>A to the Expression of Resistin Gene Affecting Serum Resistin Levels in Metabolic Syndrome in the Egyptian Population." Current Pharmaceutical Biotechnology 21, no. 7 (2020): 626–34. http://dx.doi.org/10.2174/1389201021666191210122851.
Texte intégralLovrečić, Luca, Smiljana Ristić, Nada Starčević-Čizmarević, et al. "PAI and TPA gene polymorphisms in multiple sclerosis." Multiple Sclerosis Journal 14, no. 2 (2007): 243–47. http://dx.doi.org/10.1177/1352458507082603.
Texte intégralBagos, Pantelis G., Anthi C. Karnaouri, Georgios K. Nikolopoulos, and Stavros J. Hamodrakas. "No evidence for association of CTLA-4 gene polymorphisms with the risk of developing multiple sclerosis: a meta-analysis." Multiple Sclerosis Journal 13, no. 2 (2007): 156–68. http://dx.doi.org/10.1177/1352458507078059.
Texte intégralBoyko, A. N., M. S. Kozin, G. Zh Osmak, O. G. Kulakova, and O. O. Favorova. "Mitochondrial genome and risk of multiple sclerosis." Neurology, Neuropsychiatry, Psychosomatics 11, no. 3 (2019): 43–46. http://dx.doi.org/10.14412/2074-2711-2019-3-43-46.
Texte intégralNowak, Izabela, Sylwester Ciećwież, Beata Łój, Jacek Brodowski, and Agnieszka Brodowska. "Adiponectin Gene Polymorphism (rs17300539) Has No Influence on the Occurrence of Metabolic Syndrome in Women with Polycystic Ovary Syndrome." Genes 12, no. 12 (2021): 1902. http://dx.doi.org/10.3390/genes12121902.
Texte intégralSarah Abdul Hameed Sahib, Ghassan Mohammad Sulaiman, and Huda J. Waheed. "Evaluation of the Frequency of (rs2227981 and rs2282055) Single Nucleotide Polymorphisms in Programmed Cell Death 1 and Its Ligand Genes of Iraqi Patients With Multiple Sclerosis." Iraqi Journal of Pharmaceutical Sciences( P-ISSN 1683 - 3597 E-ISSN 2521 - 3512) 33, no. 3 (2024): 209–17. http://dx.doi.org/10.31351/vol33iss3pp209-217.
Texte intégralMas, A., A. Martínez, V. De Las Heras, et al. "The 795CT polymorphism in osteopontin gene is not associated with multiple sclerosis in a Spanish population." Multiple Sclerosis Journal 13, no. 2 (2007): 250–52. http://dx.doi.org/10.1177/1352458506070944.
Texte intégralMatsuo, Keitaro, Ritsuro Suzuki, Nobuyuki Hamajima, et al. "Association between polymorphisms of folate- and methionine-metabolizing enzymes and susceptibility to malignant lymphoma." Blood 97, no. 10 (2001): 3205–9. http://dx.doi.org/10.1182/blood.v97.10.3205.
Texte intégralBarac, Ioana S., Mihaela Iancu, Vitalie Văcăraș, et al. "Potential Contribution of IL-27 and IL-23 Gene Polymorphisms to Multiple Sclerosis Susceptibility: An Association Analysis at Genotype and Haplotype Level." Journal of Clinical Medicine 11, no. 1 (2021): 37. http://dx.doi.org/10.3390/jcm11010037.
Texte intégralKurbanov, R. D., та N. Z. Srojidinova. "ROLE OF THE PPARГ PROI2ALA POLYMORPHISM IN HYPERTENSION AND METABOLIC SYNDROME". Eurasian heart journal, № 2 (30 червня 2012): 47–54. http://dx.doi.org/10.38109/2225-1685-2012-2-47-54.
Texte intégralLunev, K. V. "Association between course of multiple sclerosis and polymorphisms of calcitriol receptor gene VDR FokI (rs2228570), BSMI (rs1544410), TaqI (rs731236), ApaI (rs7975232)." Medical alphabet, no. 14 (October 19, 2023): 18–21. http://dx.doi.org/10.33667/2078-5631-2023-14-18-21.
Texte intégralValdés-Alvarado, Emmanuel, Miguel Huerta, Xochil Trujillo, et al. "Association between the -844 G>A, HindIII C>G, and 4G/5G PAI-1 Polymorphisms and Susceptibility to Multiple Sclerosis in Western Mexican Population." Disease Markers 2019 (October 7, 2019): 1–5. http://dx.doi.org/10.1155/2019/9626289.
Texte intégralAbouzid, Mohamed, Łukasz Kruszyna, Dominika Kaczmarek, et al. "Genetic Polymorphism of CYP2R1, CYP27A1, CYP27B1, and Vitamin D Metabolites Plasma Levels in Patients with Cardiovascular Disease: A Pilot Study." Biomolecules 15, no. 5 (2025): 699. https://doi.org/10.3390/biom15050699.
Texte intégralKalvaitis, Lukas, Greta Gedvilaite-Vaicechauskiene, Loresa Kriauciuniene, Renata Balnyte, and Rasa Liutkeviciene. "TNF-alfa Gene Polymorphism Associations with Multiple Sclerosis." Journal of Clinical Medicine 13, no. 13 (2024): 3693. http://dx.doi.org/10.3390/jcm13133693.
Texte intégralHuang, Q. R., S. M. Teutsch, M. McW Buhler, et al. "Evaluation of the Apo-1/Fas promoter Mva I polymorphism in multiple sclerosis." Multiple Sclerosis Journal 6, no. 1 (2000): 14–18. http://dx.doi.org/10.1177/135245850000600104.
Texte intégralYan, Jun, Jia Liu, Clement Yihao Lin, et al. "Interleukin-6 Gene Promoter-572 C Allele May Play a Role in Rate of Disease Progression in Multiple Sclerosis." International Journal of Molecular Sciences 13, no. 10 (2012): 13667–79. http://dx.doi.org/10.3390/ijms131013667.
Texte intégralChen, Ai-Rong, Hong-Gang Zhang, Zhi-Ping Wang, et al. "C-reactive protein, vitamin B12 and C677T polymorphism of N-5,10-methylenetetrahydrofolate reductase gene are related to insulin resistance and risk factors for metabolic syndrome in Chinese population." Clinical & Investigative Medicine 33, no. 5 (2010): 290. http://dx.doi.org/10.25011/cim.v33i5.14354.
Texte intégralRabago-Barajas, Brenda Viridiana, Miguel Ángel Macias-Islas, Ana Miriam Saldaña-Cruz, Jesús Emmanuel Arana-Yepez, Eva Maria Olivas-Flores, and Adriana Aguayo-Arelis. "Association of the Val66Met Polymorphism of the BDNF Gene with the Depression in a Mexican Population with Multiple Sclerosis." Life 15, no. 2 (2025): 213. https://doi.org/10.3390/life15020213.
Texte intégralLIU, Zhi-zhen, Jun-tao ZHANG, Dan LIU, et al. "Interaction between maternal 5,10-methylenetetrahydrofolate reductase C677T and methionine synthase A2756G gene variants to increase the risk of fetal neural tube defects in a Shanxi Han population." Chinese Medical Journal 126, no. 5 (2013): 865–69. http://dx.doi.org/10.3760/cma.j.issn.0366-6999.20121688.
Texte intégralAsgharzadeh, Mohammad, Zahra A. Jigheh, Hossein S. Kafil, et al. "Association of Interleukin-1 and Inteleukin-1 Receptor Antagonist Gene Polymorphisms with Multiple Sclerosis in Azeri Population of Iran." Endocrine, Metabolic & Immune Disorders - Drug Targets 20, no. 7 (2020): 1110–16. http://dx.doi.org/10.2174/1871530320666200309142541.
Texte intégralHUNT, CLIVE C. J., JODI E. BURLEY, CAROLINE M. L. CHAPMAN, and JOHN P. BEILBY. "A high-throughput MS-PCR method on MADGE gels for ANG II type-1 receptor A1166C polymorphism." Physiological Genomics 1, no. 2 (1999): 71–73. http://dx.doi.org/10.1152/physiolgenomics.1999.1.2.71.
Texte intégralPistono, Cristiana, Cecilia Osera, Maria Cristina Monti, et al. "Vitamin D Receptor and Its Influence on Multiple Sclerosis Risk and Severity: From Gene Polymorphisms to Protein Expression." Immuno 2, no. 3 (2022): 469–81. http://dx.doi.org/10.3390/immuno2030029.
Texte intégralShramko, Iuliana, Elizaveta Ageeva, Konstantin Maliy, Irina Repinskaya, and Anna Gurtovaya. "Genetic and pathophysiological substantiation of polyphenolic grape processing products’ application in the treatment of metabolic syndrome in the population of the Republic of Crimea." BIO Web of Conferences 39 (2021): 06001. http://dx.doi.org/10.1051/bioconf/20213906001.
Texte intégralLi, Keshen, Bin Zhao, Dawei Dai, et al. "A functional p.82G>S polymorphism in the RAGE gene is associated with multiple sclerosis in the Chinese population." Multiple Sclerosis Journal 17, no. 8 (2011): 914–21. http://dx.doi.org/10.1177/1352458511403529.
Texte intégralKreft, Karim L., Gijsbert P. Van Nierop, Sandra M. J. Scherbeijn, Malou Janssen, Georges M. G. M. Verjans, and Rogier Q. Hintzen. "Elevated EBNA-1 IgG in MS is associated with genetic MS risk variants." Neurology - Neuroimmunology Neuroinflammation 4, no. 6 (2017): e406. http://dx.doi.org/10.1212/nxi.0000000000000406.
Texte intégralInsha, Zahoor, Shafi Amrina, and A. Mir Mudasir. "Lack of association between CD45 C77G polymorphism and multiple sclerosis in Kashmir." International Journal of Trend in Scientific Research and Development 1, no. 6 (2017): 1333–37. https://doi.org/10.31142/ijtsrd5813.
Texte intégral唐, 宏. "Polymorphism and Cocrystal Research Progress of Vanillin." Material Sciences 12, no. 02 (2022): 112–22. http://dx.doi.org/10.12677/ms.2022.122012.
Texte intégralMasnavieva, Liudmila B., Nadezhda P. Chistova, Olga V. Naumova, and Irina V. Kudaeva. "The role of LEPR, PPARG and PPARGC1A genes polymorphisms in the development of metabolic disorders in patients with vibration diseases." Hygiene and sanitation 100, no. 7 (2021): 711–16. http://dx.doi.org/10.47470/0016-9900-2021-100-7-711-716.
Texte intégralScazzone, Concetta, Luisa Agnello, Bruna Lo Sasso, et al. "FOXP3 and GATA3 Polymorphisms, Vitamin D3 and Multiple Sclerosis." Brain Sciences 11, no. 4 (2021): 415. http://dx.doi.org/10.3390/brainsci11040415.
Texte intégralFu, Zenghui, Yan Jiang, Jing Liu, Zaihong Lin, and Yan Jin. "Study on plasma CC chemokine ligand 2 level and its promoter region 2518A/G polymorphism in MS patients." European Journal of Inflammation 18 (January 2020): 205873922095991. http://dx.doi.org/10.1177/2058739220959913.
Texte intégralGrilo, Antonio, Maria Fernandez, Manuel Beltrán, et al. "Genetic analysis of CAV1 gene in hypertension and metabolic syndrome." Thrombosis and Haemostasis 95, no. 04 (2006): 696–701. http://dx.doi.org/10.1160/th05-10-0699.
Texte intégralElchaninova, E. Yu, I. V. Smagina, A. I. Afanas’eva, and S. A. Elchaninova. "HLA-DRB1 polymorphism and risk of pediatric-onset and adult-onset multiple sclerosis: a case–control study." Russian neurological journal 28, no. 1 (2023): 33–40. http://dx.doi.org/10.30629/2658-7947-2023-28-1-33-40.
Texte intégralCozma, Angela, Adela Sitar Taut, Olga Orasan, et al. "The Relationship Between eNOS (G894T ) Gene Polymorphism and Arterial Stiffness in Patients with Metabolic Syndrome." Revista de Chimie 69, no. 9 (2018): 2351–56. http://dx.doi.org/10.37358/rc.18.9.6532.
Texte intégralKozin, M. S., I. S. Kiselev, A. N. Boyko, O. G. Kulakova, and O. O. Favorova. "The combined effect of nuclear and mitochondrial genomes on the risk of developing multiple sclerosis." Neurology, Neuropsychiatry, Psychosomatics 12, no. 1S (2020): 15–19. http://dx.doi.org/10.14412/2074-2711-2020-1s-15-19.
Texte intégral